Status:

COMPLETED

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Lead Sponsor:

City of Hope Medical Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Breast Cancer

Eligibility:

FEMALE

20+ years

Brief Summary

RATIONALE: Collecting and storing samples of blood and tumor tissue from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This clinical trial is stu...

Detailed Description

OBJECTIVES: Primary * To establish a specimen bank from peripheral blood specimens collected from women with a full spectrum of breast disease (invasive breast cancer \[IBC\], ductal or lobular carc...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Biopsy-confirmed diagnosis of one of the following:
  • Stage I-IV infiltrating ductal or infiltrating lobular carcinoma
  • Patients with early-stage disease must not have started systemic treatment; if no systemic treatment is planned, patients must be either preoperative or ≤ 120 days since definitive breast surgery
  • Patients with locally advanced disease must be scheduled for neoadjuvant chemotherapy prior to initiation of systemic treatment
  • Ductal carcinoma in situ
  • Lobular carcinoma in situ
  • Benign breast disease
  • Proliferative or non-proliferative
  • With or without atypia
  • PATIENT CHARACTERISTICS:
  • Karnofsky performance status 50-100%
  • Not pregnant
  • No prior invasive cancer diagnosis within the past 5 years except for squamous cell or basal cell carcinoma of the skin
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics
  • No prior systemic therapy (chemotherapy or hormonal therapy) for patients with stage I-III disease

Exclusion

    Key Trial Info

    Start Date :

    August 1 2005

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    June 6 2019

    Estimated Enrollment :

    563 Patients enrolled

    Trial Details

    Trial ID

    NCT00898508

    Start Date

    August 1 2005

    End Date

    June 6 2019

    Last Update

    June 25 2025

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Tower Cancer Research Foundation

    Beverly Hills, California, United States, 90211

    2

    City of Hope Comprehensive Cancer Center

    Duarte, California, United States, 91010-3000

    3

    City of Hope Medical Group

    Pasadena, California, United States, 91105

    Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | DecenTrialz